1 Recommendations
KEYWORDS: qfr, qangio, qangio qfr, coronary, ffr, vffr, caas, caas vffr, invasive, studies, angiography, diagnostic, invasive coronary, coronary angiography, clinical

11.093 £5,019 10.843 0.016 3 (grey zone) 5 ICA with CAAS vFFR 11.098 £5,118 10.842 0.016 4 NHB and INHB are measured at a maximum acceptable ICER of £20,000 per QALY gained. Incremental NHB is relative to ICA alone. Abbreviations: ICA, invasive coronary angiography; FFR, fractional flow reserve; QFR, quantitative flow ratio; vFFR, vessel FFR; QALY, quality-adjusted life year; NHB, net health benefit; INHB, incremental NHB. Table 9 Probabilistic cost-effectiveness results for base-case scenario Probability cost effective Total NHB Strategy Identification Total costs NHB INHB at £20,000 per QALY QALYs rank gained 1 ICA alone 11.039 £4,696 10.804 – 5 0.100 2 ICA with FFR 11.073 £4,825 10.831 0.027 1 0.278 3 ICA with QAngio QFR 11.065 £4,813 10.824 0.020 2 0.218 ICA with QAngio QFR and 4 confirmatory FFR (grey 11.070 £5,020 10.819 0.015 4 0.199 zone) 5 ICA with CAAS vFFR 11.076 £5,119 10.820 0.016 3 0.204 NHB and INHB are measured at a maximum acceptable ICER of £20,000 per QALY gained. Incremental NHB is relative to ICA alone. Abbreviations: ICA, invasive coronary angiography; FFR, fractional flow reserve; QFR, quantitative flow ratio; vFFR, vessel FFR; QALY, quality-adjusted life year; NHB, net health benefit; INHB, incremental NHB. 3.52 Strategy
